Northpointe Capital’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-35,222
| Closed | -$1.17M | – | 147 |
|
|
2018
Q4 | $1.17M | Sell |
35,222
-20,373
| -37% | -$677K | 0.26% | 142 |
|
|
2018
Q3 | $2.8M | Sell |
55,595
-2,992
| -5% | -$151K | 0.4% | 124 |
|
|
2018
Q2 | $3.51M | Sell |
58,587
-92,822
| -61% | -$5.55M | 0.46% | 93 |
|
|
2018
Q1 | $6.94M | Sell |
151,409
-88,488
| -37% | -$4.05M | 0.87% | 33 |
|
|
2017
Q4 | $9.56M | Sell |
239,897
-11,629
| -5% | -$463K | 1.07% | 25 |
|
|
2017
Q3 | $10.1M | Sell |
251,526
-26,200
| -9% | -$1.05M | 1.07% | 19 |
|
|
2017
Q2 | $12M | Sell |
277,726
-148,271
| -35% | -$6.39M | 1.25% | 14 |
|
|
2017
Q1 | $13.3M | Sell |
425,997
-104,186
| -20% | -$3.26M | 1.45% | 8 |
|
|
2016
Q4 | $13.4M | Sell |
530,183
-84,878
| -14% | -$2.14M | 1.33% | 16 |
|
|
2016
Q3 | $15.2M | Sell |
615,061
-146,142
| -19% | -$3.61M | 1.58% | 10 |
|
|
2016
Q2 | $15.5M | Sell |
761,203
-10,216
| -1% | -$208K | 1.83% | 2 |
|
|
2016
Q1 | $11.8M | Buy |
771,419
+186,666
| +32% | +$2.85M | 1.46% | 8 |
|
|
2015
Q4 | $8.2M | Hold |
584,753
| – | – | 1.08% | 23 |
|
|
2015
Q3 | $8.2M | Sell |
584,753
-303,926
| -34% | -$4.26M | 1.07% | 23 |
|
|
2015
Q2 | $15.1M | Sell |
888,679
-319,579
| -26% | -$5.43M | 1.77% | 5 |
|
|
2015
Q1 | $14.6M | Buy |
1,208,258
+227,196
| +23% | +$2.75M | 1.58% | 6 |
|
|
2014
Q4 | $8.14M | Sell |
981,062
-153,385
| -14% | -$1.27M | 0.98% | 25 |
|
|
2014
Q3 | $9.86M | Buy |
1,134,447
+114,628
| +11% | +$996K | 1.05% | 23 |
|
|
2014
Q2 | $11.2M | Sell |
1,019,819
-50,079
| -5% | -$548K | 1.08% | 20 |
|
|
2014
Q1 | $9.56M | Buy |
+1,069,898
| New | +$9.56M | 0.97% | 42 |
|